Home International News WHO Launches First-Ever RSV Vaccine for Babies: What Every Parent Needs to Know Now
International NewsWHO

WHO Launches First-Ever RSV Vaccine for Babies: What Every Parent Needs to Know Now

Share
WHO
WHO
Share

New Delhi, 03 June 2025: The World Health Organization (WHO) released a groundbreaking position paper introducing two new tools to protect infants from Respiratory Syncytial Virus (RSV): a maternal vaccine and a monoclonal antibody injection. These advancements offer hope to families worldwide, especially in low- and middle-income countries where RSV mortality rates are high.

What Is RSV and Why Is It Dangerous for Babies?

Respiratory Syncytial Virus (RSV) is a common virus that affects the lungs and respiratory tract. While it usually causes mild, cold-like symptoms in older children and adults, RSV can be severe and even fatal for infants, particularly those under six months of age.

Key Facts About RSV:

RSV is seasonal, typically peaking during colder months in most regions.

RSV is the leading cause of hospitalization in babies under 1 year of age.

It can cause serious complications such as bronchiolitis and pneumonia.

It spreads easily through coughs, sneezes, and contaminated surfaces.

The Two-Pronged Approach to RSV Prevention

1. Maternal Vaccination: Abrysvo

Pfizer’s Abrysvo is a bivalent RSV vaccine approved for use during pregnancy. Administered between 32 and 36 weeks of gestation, it helps protect newborns from severe RSV illness by transferring antibodies from mother to baby. Clinical studies have shown that Abrysvo reduces the risk of RSV-related hospitalization in infants by 57% during the first six months after birth.

2. Monoclonal Antibody Injection: Nirsevimab (Beyfortus)

Nirsevimab, marketed as Beyfortus, is a monoclonal antibody designed to provide immediate protection against RSV. A single intramuscular dose is recommended for:

  • All infants under 8 months of age entering their first RSV season.
  • Children aged 8 to 19 months at high risk for severe RSV disease, such as those with chronic lung disease or congenital heart conditions.

Nirsevimab has been shown to reduce the risk of medically attended RSV lower respiratory tract infections by approximately 70% in preterm infants and 75% in term and late preterm infants.

Eligibility and Timing for Immunization

  • Maternal Vaccine (Abrysvo): Pregnant individuals between 32 and 36 weeks gestation during RSV season.
  • Nirsevimab (Beyfortus): Infants under 8 months of age entering their first RSV season, and certain high-risk children aged 8 to 19 months.

It’s important to note that most infants will require protection from either the maternal vaccine or the monoclonal antibody, but not both.

Safety and Side Effects

Both Abrysvo and Nirsevimab have undergone extensive clinical trials to assess their safety profiles. Common side effects for Nirsevimab include rash, fever, and injection site reactions such as redness or swelling. No major hypersensitivity reactions have been reported.

What Parents Need to Know

  • Consult Healthcare Providers: Discuss with your obstetrician or pediatrician about the best preventive measure for your baby, considering factors like gestational age and health conditions.
  • Timing is Crucial: Ensure vaccinations or antibody injections are administered at the recommended times to maximize effectiveness.
  • Monitor for Side Effects: Be aware of potential side effects and report any concerns to your healthcare provider.

The WHO’s endorsement of the world’s first RSV vaccine for babies is a major step forward in global child health. For decades, RSV has caused hospitalizations and deaths among infants, with limited preventive options. Now, thanks to maternal immunization and monoclonal antibodies, parents have powerful tools to safeguard their babies from this serious respiratory virus.

Share
Written by
kirti Shah

Kirti is a Health Editor at Healthwire Media, specializing in health journalism and digital health communication. With over four years of experience in the healthcare media landscape, she is dedicated to transforming complex clinical data into accessible, patient-friendly information. Kirti oversees the editorial lifecycle of every article, ensuring they meet rigorous fact-checking standards and align with the latest guidelines from primary sources like the WHO and Ministry of Health. In her role, Kirti works closely with a panel of board-certified physicians and medical reviewers to ensure that every piece of content published is not only easy to understand but also medically accurate and safe for the public. She is passionate about health literacy and helping readers navigate their wellness journeys with confidence.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Always Tired? It Could Be Anaemia!
Diet & NutritionHealth NewsHealth TipsLifestyleLifestyle & WellnessWellness

Anaemia in India: Why Iron Deficiency Remains a Concern and 7 Signs You Should Not Ignore

Feeling tired all the time, experiencing frequent dizziness or getting breathless after climbing a few stairs? While these symptoms are often dismissed as...

N95 Mask
Health TipsLatest NewsLifestyle & WellnessWellness

Does Wearing an N95 Mask Protect You From PM2.5 Pollution? Doctors Explain How To Choose And Wear It Correctly

As air pollution continues to affect several Indian cities during winter, wearing a mask has become an important precaution for people stepping outdoors....

Delhi Air Pollution
Lifestyle & Wellness

Can Air Pollution Cause Pneumonia? Doctors Explain How Poor AQI Affects Your Lungs This Winter

Winter brings a familiar set of respiratory health concerns, from persistent coughing and throat irritation to breathing difficulties and chest infections. However, as...

Diet & NutritionHealth TipsLatest NewsLifestyleLifestyle & WellnessWellness

Weight Loss Diet: 10 Drinks That May Help You Lose Weight

Losing weight is not just about eating healthy and exercising. What you drink during the day also matters. Some drinks can help you...

Heart Attack
Lifestyle & Wellness

Diabetes and Heart Disease: Why High Blood Sugar Can Increase Your Risk of a Heart Attack

Diabetes is often considered a condition that primarily affects blood sugar levels. However, its impact extends far beyond glucose regulation. Persistently high blood...

Section title

Related Articles
Latest NewsWHO

WHO Releases First-Ever Guidelines For Type 1 Diabetes In Adults: 5 Key Recommendations Explained

The World Health Organization (WHO) has issued its first-ever guidelines for the...

Bundibugyo Ebola virus
International NewsVirus & DiseaseWHO

From Fever To Organ Failure: How The Bundibugyo Ebola Virus Affects The Body

The Bundibugyo Ebola virus outbreak has raised fresh global health concerns as...

New Covid Variant PJ.2.1
International NewsLatest NewsVirus & Disease

New COVID Variant PJ.2.1: What You Should Know

A new COVID-19 variant, PJ.2.1, is drawing attention after being detected in...